¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"persistent fetal circulation"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® persistent vegetative state ÇÑ±Û Áö¼Ó½Ä¹°»óÅÂ
¼³¸í   
  ±× ºÎÀ§¿¡ »ó°ü¾øÀÌ ³ú¼Õ»ó¿¡ ÀÇÇØ¼­ ÀϾ´Â °¢¼º»óÅ¿¡ À־ÀÇ ½ÉÇÑ ¹«¹ÝÀÀ»óÅ·μ­, ´ë³ú°ÑÁúÀÇ ±â´ÉÁ¤Áö, ¿ÜºÎȯ°æ¿¡ ´ëÇÑ ÀûÀýÇÑ ÀûÀÀ¹ÝÀÀÀÇ °á¿©, ¹«µ¿, ¹«¾ðÀ» Æ¯Â¡À¸·Î Çϸç, ³úÆÄ´Â Æòźȭ ¶Ç´Â ÀÌ»óȰµ¿À» ³ªÅ¸³½´Ù.
¿µ¹® systemic circulation ÇÑ±Û Ã¼¼øÈ¯
¼³¸í   
  ¿Þ½É½Ç¿¡¼­ ½Åü¸¦ µ¹¾Æ ¿À¸¥½É¹æ±îÁöÀÇ ¼øÈ¯À» ÀǹÌÇϸç, ¿Þ½É½Ç ¡æ ´ëµ¿¸Æ ¡æ µ¿¸Æ ¡æ ¸ð¼¼Ç÷°ü ¡æ Á¤¸Æ ¡æ ´ëÁ¤¸Æ ¡æ ¿À¸¥½É¹æÀǠȸ·Î¸¦ ¼øÈ¯ÇÑ´Ù.
¿µ¹® extracorporeal circulation ÇÑ±Û Ã¼¿Ü¼øÈ¯, ¸ö¹Û¼øÈ¯
¼³¸í   
  Ã¼¿ÜÀÇ ÀΰøÈ¸·Î¸¦ µû¶ó ÀÌ·ç¾îÁö´Â ¼øÈ¯¹ý. Ç÷°ü³»¿¡ »ðÀÔÇÑ Æ©ºê¸¦ ÅëÇÏ¿© Ç÷¾×À» Àϴܠü¿Ü·Î ³»º¸³»¼­, ÆßÇÁ¿¡ ÀÇÇÏ¿© ¿¬¼ÓÇÏ¿© ÀçÂ÷ Ã¼³»¿¡ µÇµ¹¸®´Â ¼øÈ¯À» Ã¼¿Ü¼øÈ¯À̶ó°í ÇÑ´Ù. ¿©·¯ °¡ÁöÀÇ ¸ñÀûÀ» À§ÇÏ¿© »ç¿ëµÇ¸ç, ¿©·¯ °¡ÁöÀÇ ¹æ½ÄÀÌ ÀÖ´Ù. °¡À堳θ® »ç¿ëµÇ°í ±âº»À¸·Î µÇ¾î Àִ °ÍÀº, Àΰø½ÉÆó¿¡ ÀÇÇѠü¿Ü¼øÈ¯À¸·Î »ó-ÇÏ´ëÁ¤¸Æ¿¡ »ðÀÔÇÑ »ð°üÀ» ÅëÇÏ¿© ½ÉÀåÀ¸·Î µÇµ¹¾Æ°¡´Â Á¤¸ÆÇ÷À» Ã¼¿Ü¿¡ Àִ »ê¼ÒÈ­ÀåÄ¡·Î À̲ø¾î¼­ »ê¼Ò¸¦ °¡ÇÑ ÈÄ, ÆßÇÁ¿¡ ÀÇÇÏ¿© µ¿¸Æ³»·Î º¸³»´Â ¹æ½ÄÀ¸·Î ½ÉÀåÀ¸·ÎÀǠȯ·ùÇ÷ÀÇ ÀüºÎ¸¦ »ê¼ÒÈ­ÀåÄ¡·Î À̲ô´Â °æ¿ì¸¦ ¿ÏÀüü¿Ü¼øÈ¯, ÀϺκи¸À» À̲ô´Â °æ¿ì¸¦ ºÎºÐü¿Ü¼øÈ¯À̶ó°í ÇÑ´Ù. À̿ܿ¡ Á½ɵθ§±æ¹ý, ¿ì½ÉµÎ¸§±æ¹ý, ½ÅüÀÇ ÀϺκи¸ÀǠü¿Ü¼øÈ¯, º¸Á¶¼øÈ¯µîÀÌ ÀÖ´Ù.
¿µ¹® fetal monitoring ÇÑ±Û Å¾ư¨½Ã
¼³¸í   
  ÀӽŠÁßÀ̳ª ºÐ¸¸ ÁßÀǠžÆÀÇ »óŸ¦ ¾Ë¾Æº¸´Â °ÍÀ» Å¾ư¨½Ã¶ó°í ÇÑ´Ù. ¿©±â¿¡´Â ¿©·¯ °¡Áö ¹æ¹ýÀÌ Àִµ¥ Å©°Ô ºÐ¸¸Àü Å¾ư¨½Ã¿Í ºÐ¸¸Áߠžư¨½Ã·Î Å©°Ô ³ª´«´Ù.
  
  1. ºÐ¸¸Àü Å¾ư¨½Ã´Â ºÐ¸¸Çϱâ ÀÌÀüÀǠžÆÀÇ »óŸ¦ °Ë»çÇϴ ¹æ¹ýÀ¸·Î ´ÙÀ½°ú °°Àº ¿©·¯ °¡Áö ¹æ¹ýÀÌ ÀÖ´Ù.
  
    1)¾ç¼öõÀÚ-ÁÖ»ç±â¸¦ ÀÌ¿ëÇØ¼­ »ê¸ðÀÇ ¹è¸¦ ÅëÇØ¼­ ¾ç¼ö¸¦ ¾ò¾î¼­ ºÐ¼®ÇÏ¿© Å¾ÆÀÇ »óŸ¦ ¾Ë¾Æº¸´Â ¹æ¹ý. ÀӽŠ15ÁÖ À̻󿡼­ ½Ç½ÃÇÒ ¼ö°¡ ÀÖ´Ù.
  
    2)ÅÈÁÙõÀÚ-ÃÊÀ½ÆÄ°Ë»ç¸¦ ½Ç½ÃÇÏ¿© ¿µ»óÀ» º¸¸é¼­ ÅÈÁÙ¼Ó¿¡ ¹Ù´ÃÀ» ³Ö¾î¼­ ±×°÷ÀÇ Ç÷°üÀ» Ã£¾Æ Ç÷¾×À» Ã¤ÃëÇÏ¿© °Ë»çÇϴ ¹æ¹ý.
  
    3)½ºÆ®·¹½º°Ë»ç-žƵµ Àڱüӿ¡¼­ ¿îµ¿À» ÇÑ´Ù. ±×¸®°í Á¤»óÀûÀ¸·Î Å¾ư¡ Àڱüӿ¡¼­ ¿îµ¿À» ÇÒ °æ¿ì¿¡´Â Å¾ÆÀÇ ½ÉÀå ¹Úµ¿ÀÌ »¡¶óÁö°Ô µÈ´Ù. Å¾ÆÀÇ ¿îµ¿°ú Å¾ÆÀÇ ½ÉÀå¹Úµ¿À» µ¿½Ã¿¡ °¨½ÃÇÏ¿© ¿îµ¿½Ã¿¡ Å¾ÆÀÇ ½ÉÀå¹Úµ¿ÀÌ »¡¶óÁö´Â °¡¸¦ ¾Ë¾Æº¸´Â °ÍÀÌ´Ù.
  
    4)žÆÃ»°¢Àڱذ˻ç-30ÁÖ ÀÌ»óÀÌ µÈ Å¾ƴ ¼Ò¸®ÀÇ Àڱؿ¡ ´ëÇØ¼­ ¹ÝÀÀÀ» ÇÑ´Ù. Áï ¼Ò¸®¸¦ µé·ÁÁÖ¾úÀ» °æ¿ì¿¡ Å¾ư¡ ¹ÝÀÀÀ» Çؼ­ ½ÉÀåÀÇ ¹Úµ¿¼ö°¡ Áõ°¡¸¦ ÇÑ´Ù.
  
    5)¼öÃེƮ·¹½º°Ë»ç-Á¤»óÀûÀΠžƴ ÀÚ±ÃÀÌ ¼öÃàÇϸé ÀÌ¿¡ ¹ÝÀÀÀ» Çؼ­ ½É¹Ú¼ö°¡ º¯È­ÇÑ´Ù. À̰ÍÀ» ÀÌ¿ëÇÏ¿© Å¾ÆÀÇ »óŸ¦ °Ë»çÇϴ ¹æ¹ýÀÌ´Ù.
  
  2. ºÐ¸¸Áߠžư¨½Ã
  
  ºÐ¸¸µµÁß¿¡ Å¾ÆÀÇ °Ç°­»óŸ¦ °¨½ÃÇϴ °ÍÀÌ´Ù. ´ëü·Î ºÐ¸¸µµÁß¿¡ Å¾ư¡ Àú»ê¼ÒÁõÀ̳ª ¿©·¯ °¡Áö Ãæ°ÝÀ» ¹Þ´Â °æ¿ì°¡ ¸¹À¸¹Ç·Î ºÐ¸¸µµÁßÀǠžư¨½Ã´Â Áß¿äÇÑ Àǹ̸¦ °¡Áø´Ù.
  
    1)ÀüÀڽĞư¨½Ã-Àü±âÀû ÀåÄ¡¸¦ ÀÌ¿ëÇÏ¿© Å¾ÆÀÇ »óŸ¦ ¾Ë¾Æº¸´Â °ÍÀ¸·Î °¨½ÃÀÇ ´ë»óÀº ÀÚ±ÃÀÇ ¼öÃà°ú Å¾ÆÀÇ ½ÉÀå¹Úµ¿¼öÀÌ´Ù.
  
    2)žƸӸ®µ¤°³ Ç¥º»Ã¤Ãë Ç÷¾×-ºÐ¸¸µµÁß¿¡ Å¾ÆÀÇ µÎÇÇÀÇ Ç÷°ü¿¡¼­ Ç÷¾×À» Ã¤ÃëÇÏ¿© °Ë»ç¸¦ ÅëÇØ¼­ Å¾ÆÀÇ »óŸ¦ ¾Æ´Â ¹æ¹ýÀÌ´Ù. ÁַΠ°Ë»ç¸¦ ÇàÇϴ Á¾¸ñÀº Ç÷¾×ÀÇ pHÀÌ´Ù.
¿µ¹® fetal assessment ÇÑ±Û Å¾ƻçÁ¤
¼³¸í   
  ÀӽŠÁßÀ̳ª ºÐ¸¸ ÁßÀǠžÆÀÇ »óŸ¦ ¾Ë¾Æº¸´Â °ÍÀ» Å¾ư¨½Ã¶ó°í ÇÑ´Ù. ¿©±â¿¡´Â ¿©·¯ °¡Áö ¹æ¹ýÀÌ Àִµ¥ Å©°Ô ºÐ¸¸Àü Å¾ư¨½Ã¿Í ºÐ¸¸Áߠžư¨½Ã·Î Å©°Ô ³ª´«´Ù. 1. ºÐ¸¸Àüžư¨½Ã: ºÐ¸¸Çϱâ ÀÌÀüÀǠžÆÀÇ »óŸ¦ °Ë»çÇϴ ¹æ¹ýÀ¸·Î ´ÙÀ½°ú °°Àº ¿©·¯ °¡Áö ¹æ¹ýÀÌ ÀÖ´Ù. ¨ç ¾ç¼öõÀÚ: ÁÖ»ç±â¸¦ ÀÌ¿ëÇØ¼­ »ê¸ðÀÇ ¹è¸¦ ÅëÇØ¼­ ¾ç¼ö¸¦ ¾ò¾î¼­ ºÐ¼®ÇÏ¿© Å¾ÆÀÇ »óŸ¦ ¾Ë¾Æº¸´Â ¹æ¹ý. ÀӽŠ15ÁÖ À̻󿡼­ ½Ç½ÃÇÒ ¼ö ÀÖ´Ù. ¨è ÅÈÁÙõÀÚ: ÃÊÀ½ÆÄ°Ë»ç¸¦ ½Ç½ÃÇÏ¿© ¿µ»óÀ» º¸¸é¼­ ÅÈÁÙ ¼Ó¿¡ ¹Ù´ÃÀ» ³Ö¾î¼­ ±× °÷ÀÇ Ç÷°üÀ» Ã£¾Æ Ç÷¾×À» Ã¤ÃëÇÏ¿© °Ë»çÇϴ ¹æ¹ý. ¾ÆÁÖ À§ÇèÇÒ °Í °°Áö¸¸ »ó´çÈ÷ ¾ÈÀüÇÑ °ÍÀ¸·Î µÇ¾î ÀÖ´Ù. ´Ù¸¥ °Ë»ç¿¡ ºñÇØ¼­ °Ë»ç¿¡ ¸¹Àº ±â¼úÀÌ ÇÊ¿äÇÏÁö¸¸ ¾ÆÁÖ ¸¹Àº Á¤º¸¸¦ Á¦°øÇØ ÁØ´Ù. ¨é ºñ½ºÆ®·¹½º°Ë»ç(nonstress test) : Å¾Ƶµ Àڱà¼Ó¿¡¼­ ¿îµ¿À» ÇÑ´Ù. ±×¸®°í Á¤»óÀûÀ¸·Î Å¾ư¡ Àڱà¼Ó¿¡¼­ ¿îµ¿À» ÇÒ °æ¿ì¿¡´Â Å¾ÆÀÇ ½ÉÀå ¹Úµ¿ÀÌ »¡¶óÁö°Ô µÈ´Ù. Å¾ÆÀÇ ¿îµ¿°ú Å¾ÆÀÇ ½ÉÀå¹Úµ¿À» µ¿½Ã¿¡ °¨½ÃÇÏ¿© ¿îµ¿½Ã¿¡ Å¾ÆÀÇ ½ÉÀå¹Úµ¿ÀÌ »¡¶óÁö´Â °¡¸¦ ¾Ë¾Æº¸´Â °ÍÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fetal circulation
    žƼøÈ¯
  • persistent fetal hemoglobin
    Áö¼ÓžÆÇ÷»ö¼Ò
  • arm-to-retina circulation time
    ÆÈ¸Á¸·¼øÈ¯½Ã°£
  • circulation
    ¼øÈ¯
  • circulation time
    ¼øÈ¯½Ã°£
  • collateral circulation
    °ç¼øÈ¯
  • compensatory circulation
    º¸»ó¼øÈ¯
  • coronary circulation
    °ü»óµ¿¸Æ¼øÈ¯, ½ÉÀ嵿¸Æ¼øÈ¯
  • cross circulation
    ±³Â÷¼øÈ¯
  • chronic persistent hepatitis
    ¸¸¼ºÁö¼Ó°£¿°
  • extracorporeal circulation
    ü¿Ü¼øÈ¯, ¸ö¹Û¼øÈ¯
  • enterohepatic circulation
    âÀÚ°£¼øÈ¯, Àå°£¼øÈ¯
  • omphalomesenteric circulation
    ¹è²ÅâÀÚ°£¸·¼øÈ¯
  • ostium primum persistent
    ù°±¸¸ÛÁö¼Ó(Áõ), ÀÏÂ÷°ø°³Á¸(Áõ)
  • placental circulation
    ŹݼøÈ¯
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • persistent vegetative state
    Áö¼Ó½Ä¹°»óÅÂ
  • circulation
    ¼øÈ¯
  • collateral circulation
    °ç¼øÈ¯
  • portal circulation
    ¹®¸Æ¼øÈ¯
  • systemic circulation
    ¿Â¸ö¼øÈ¯, ü¼øÈ¯
  • fetal anemia
    žƺóÇ÷
  • fetal head compression
    žƸӸ®¾Ð¹Ú
  • severe fetal distress
    ½ÉÇÑžÆÀý¹Ú°¡»ç, ½ÉÇÑžưíÅë
  • fetal
    žÆ-
  • fetal hypoxia
    žÆÀú»ê¼ÒÁõ
  • fetal head
    žƸӸ®
  • fetal infection
    žư¨¿°
  • fetal pole
    ¹è¾Æ±Ø
  • fetal death rate
    žƻç¸Á·ü
  • fetal heart rate
    žƽɹڼö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fetal circulation
    žƼøÈ¯
  • persistent fetal hemoglobin
    Áö¼ÓžÆÇ÷»ö¼Ò
  • arm-to-retina circulation time
    ÆÈ¸Á¸·¼øÈ¯½Ã°£
  • circulation
    ¼øÈ¯
  • collateral circulation
    °ç¼øÈ¯
  • compensatory circulation
    (¢¡collateral circulation) °ç¼øÈ¯
  • coronary circulation
    ½ÉÀ嵿¸Æ¼øÈ¯
  • cross circulation
    ±³Â÷¼øÈ¯
  • enterohepatic circulation
    âÀÚ°£¼øÈ¯
  • extracorporeal circulation
    ü¿Ü¼øÈ¯, ¸ö¹Û¼øÈ¯
  • omphalomesenteric circulation
    (¢¡vitelline circulation) ³­È²¼øÈ¯
  • placental circulation
    ŹݼøÈ¯
  • portal circulation
    ¹®¸Æ¼øÈ¯
  • systemic circulation
    ¿Â¸ö¼øÈ¯, ü¼øÈ¯
  • vitelline circulation
    ³­È²¼øÈ¯
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Fetal circulation
    žƼøÈ¯(÷Ãä®âàü»)
  • Intestinal circulation
    Àå°ü¼øÈ¯(íóηâàü»)
  • Lymphatic circulation
    ¸²ÇÁ¼øÈ¯(¡­âàü»)
  • arm-to-retina circulation time
    ÆÈ¸Á¸·¼øÈ¯½Ã°£, ¿Ï-¸Á¸·¼øÈ¯½Ã°£
  • artificial circulation
    Àΰø¼øÈ¯.
  • general circulation
    ´ë¼øÈ¯(ÓÞâàü»).
  • general circulation
    ´ë¼øÈ¯.
  • grater circulation
    ´ë¼øÈ¯.
  • greater circulation
    ´ë¼øÈ¯(ÓÞâàü»).
  • hypophysioportal circulation
    ³úÇϼöü¹®¸Æ¼øÈ¯, Çϼöü¹®¼øÈ¯(¡­Ú¦âàü»).
  • hypothalamohypophyseal portal circulation
    ½Ã»óÇϺγúÇϼöü¹®¸Æ¼øÈ¯.
  • placental circulation
    ŹݼøÈ¯(¡­âàü»).
  • portal circulation
    ¹®¸Æ¼øÈ¯(¡­âàü»).
  • pulmonary circulation time
    Æó¼øÈ¯½Ã°£(¡­ãÁÊà).
  • F hemoglobin fetal
    žƼº(÷Ãä®àõ) Çì¸ð±Û·Îºó
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • persistent fetal circulation
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • persistent fetal hemoglobin
  • fetal circulation
    žƼøÈ¯(¡­âàü»), žÆÇ÷Çà(¡­úìú¼).
  • acral persistent papular mucinosis
    ¸»´Ü Áö¼Ó¼º ±¸Áø¼º Á¡¾×Áõ
  • asymptomatic persistent proteinuria
    ¹«Áõ»óÁö¼Ó¼º ´Ü¹é´¢.
  • chronic persistent hepatitis
    ¸¸¼º Áö¼Ó¼º °£¿°
  • growing teeth from persistent pulp
    »ó»ýÄ¡ (ßÈßæöÍ).
  • hepatitis,chronic persistent
    ¸¸¼ºÁö¼Ó¼º(Ø·àõò¥áÙàõ)
  • infection, persistent
    Áö¼Ó°¨¿°
  • persistent Mullerian duct syndrome
  • persistent acantholytic dermatosis
    Áö¼Ó¼º ±Ø¼¼Æ÷ÇØ¸® ÇǺκ´
  • persistent atrioventricular canal
    ¹æ½Ç±¸°³ Á¸Áõ.
  • persistent atrioventricular communis
    °øÅë ¹æ½Ç±¸(°ø)°³Á¸(Áõ)(Íì÷×Û®ãøÏ¢ÍîËÒðíñø).
  • persistent cathod ray tube
    Áö¼Ó¼º À½±Ø¼±°ü
  • persistent cloaca
    ¹è¼³°­Á¸¼ÓÁõ
  • persistent generalized lymphadenopathy
    Áö¼Ó¼º Àü½Å¼º ¸²ÇÁ¼±Áõ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Embryonic circulation
    žƼøÈ¯
    [¿¾ ¿ë¾î] žƼøÈ¯
  • Fetal inclusion
    ºÀÀÔžÆ
    [¿¾ ¿ë¾î] ºÀÀÔ±âÇüžÆ
  • Vitamin deficiency (Fetal osteodystrophy)
    ºñŸ¹Î°áÇÌ(žƻÀ¿µ¾çÀå¾Ö)
    [¿¾ ¿ë¾î] ºñŸ¹Î°áÇÌ(žƻÀ¿µ¾çÀå¾Ö)
  • Fetal period
    žƱâ
    [¿¾ ¿ë¾î] žƱâ
  • Defect of fetal membrane
    žƸ·°áÇÔ
    [¿¾ ¿ë¾î] Ÿ·°áÇÔ
  • Fetal part
    žƺκÐ
    [¿¾ ¿ë¾î] žƺÎ
  • Fetal parts
    žƺκÐ
    [¿¾ ¿ë¾î] žƺÎ
  • Definitive fetal period
    žƿϼº±â
    [¿¾ ¿ë¾î] žƿϼº±â
  • Fetal cotyledon
    žÆÂÊŹݿ±
    [¿¾ ¿ë¾î] žÆÃøÅ¹ݿ±
  • Initial fetal period
    žÆÃʱâ
    [¿¾ ¿ë¾î] žÆÀü±â
  • Fetal lung
    žÆÇãÆÄ
    [¿¾ ¿ë¾î] ÅÂ¾ÆÆó
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fetal hemoglobin
    žÆ(÷Ãä®) È÷¸ð±Û·Îºó
  • persistent induction
    Áö¼Ó À¯µµ(ò¥áÙë¯Óô)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fetal circulation
    žƼøÈ¯, žÆÇ÷Çà
  • persistent cathod ray tube
    Áö¼Ó¼ºÀ½±Ø¼±°ü
  • persistent primitive hypoglossal artery
    ¿ø½Ã¼³Çϵ¿¸Æ°³Á¸(Áõ)
  • persistent thymus
    Á¸¼ÓÈä¼±
  • collateral circulation
    ÃøºÎ¼øÈ¯, ÃøºÎÇ÷Çà
  • derivative circulation
    À¯µµ¼øÈ¯
  • fetal
    žÆÀÇ, ų»ÀÇ
  • fetal death
    žƻç¸Á
  • fetal distress syndrome
    žưï¶õÁõÈıº
  • fetal hemoglobin
    žƼºÇì¸ð±Û·Îºó, žƼºÇ÷»ö¼Ò
  • fetal position
    ÅÂÀ§
  • fetal sac
    ų¶
  • hypothalamohypophyseal portal circulation
    ½Ã»óÇϺγúÇϼöü¹®¸Æ¼øÈ¯
  • portal circulation
    ¹®¸Æ¼øÈ¯
  • pulmonary circulation
    Æó¼øÈ¯
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HCG, hCG Human Chorionic Gonadotropin; »ç¶÷À¶¸ð¼º¼º¼±ÀÚ±ØÈ£¸£¸ó
  1. Placental Glycoprotein Hormone
&nbs...
PFC Persistent Fetal Circulation; ÅÂ¾Æ ¼øÈ¯ Áö¼ÓÁõ
  = PPHN
PFC pair-fed control [mice]; patient-focused care; pelvic flexion contracture; perfluorocarbon; pericard...
PVS percussion, vibration, suction; persistent vegetative state; persistent viral syndrome; Plummer-Vins...
PMP pain management program; patient management program; patient medication profile; peripheral myelin p...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
"PFC" Persistent fetal circulation
ECC extra corporal circulation
EC Extracorporeal circulation
MCT Mean Circulation Time
ROSC Return of spontaneous circulation
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • P29.3
    Persistent fetal circulation
    Áö¼Ó¼º ÅÂ¾Æ ¼øÈ¯
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • persistent activity
    Áö¼ÓÀûÀΠȰ¼º
  • persistent generalized lymphadenopathy
    Áö¼ÓÀûÀÎ Àü½Å ¸²ÇÁÀýÁõ
  • persistent Müllerian duct syndrome
    ¹Á·¯°ü À¯Á¸ ÁõÈıº
    ¹Á·¯°ü ±¸Á¶, Áï ÀáÀç °íȯ, ¾çÃø¼º Á¤·ù °íȯ, ¾çÃø¼º Àڱðú, ÀÚ±Ã, »óºÎÁúÀÇ Áö¼ÓÀû ÀÜÁ¸ »óŸ¦ ³ªÅ¸³»´Â Áúȯ. ÀÏÃø¼º ÀáÀç °íȯ ¹× ¹Ý´ëÃø ¼­ÇýºÎ Å»ÀåÀÌ µ¿¹ÝµÇ±âµµ ÇÏ´Â À¯Àü¼º ÁúȯÀÌ´Ù.
  • persistent painful disc derangement
    Áö¼ÓÀûÀÎ µ¿Å뼺 °üÀý¿øÆÇ ³»Àå
  • persistent primitive hypoglossal artery
    ¿ø½Ã ¼³ÇÏ µ¿¸Æ °³Á¸, ¿ø½Ã ¼³ÇÏ µ¿¸Æ °³Á¸Áõ
  • persistent truncus arteriosus
    µ¿¸Æ°£ ÀÜÁ¸
  • persistent vegetative state
    Áö¼ÓÀû ½Ä¹° »óÅÂ
  • venae cava superior, persistent left
    Á¸¼Ó¼º Á»ó ´ëÁ¤¸Æ
    Á»ó ´ëÁ¤¸ÆÀÌ »ýÈÄ¿¡µµ Á¸¼ÓÇÏ´Â ¹ß»ýÇÐÀû ±âÇüÀ¸·Î¼­ º¸Åë Á½ɹ濡 Ç÷¾×À» ºñ¿î´Ù. ÁÂÀüÁÖ Á¤¸Æ »óºÎÀÇ Æó¼â Àå¾Ö¿¡ ÀÇÇÑ´Ù. ´Üµ¶¼º ±âÇüÀÇ °æ¿ìµµ ÀÖ°í Follot 4¡ÈÄ¿Í °°Àº ´Ù¸¥ ½ÉÇ÷°ü Àå¾Ö¸¦ ¼ö¹ÝÇÏ´Â °æ¿ìµµ ÀÖ´Ù.
  • abnormal fetal presentation
    ÀÌ»ó ÅÂÀ§
    žÆÀÇ À§Ä¡°¡ ºñÁ¤»óÀûÀÎ °Í.
  • fetal alcohol
    ÅÂ¾Æ ¾ËÄÝ
  • fetal antigen
    ÅÂ¾Æ Ç׿ø
    Á¾¾ç °ü·Ã Ç׿øÀÇ ÀÏÁ¾, Å»ý±â Á¶Á÷¿¡¼­´Â ÀÎÁ¤µÇÁö¸¸, Á¤»óÀûÀÎ ºÐÈ­¸¦ ¹âÀº Á¶Á÷¿¡¼­´Â ÀÎÁ¤µÇÁö ¾Ê°Å³ª ±ØÈ÷ ¹Ì·® Á¸ÀçÇϰųª ÇÑ´Ù.
  • fetal cartilage
    ų» ¿¬°ñ
  • fetal cretinism
    ÅÂ¾Æ °©»ó¼± ±â´É ÀúÇÏÁõ
  • fetal distress syndrome
    ÅÂ¾Æ °ï¶õ ÁõÈıº
  • fetal hemoglobin
    žƼº Çì¸ð±Û·Îºó
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
persistent foetal circulation syndrome <syndrome> A syndrome of persistent pulmonary hypertension in the newborn infant, without demonstrable cardiac disease. It is characterised by cyanosis and acidosis, severe pulmonary vasoconstriction, hypertrophy of pulmonary arterial muscle, and elevated pulmonary vascular resistance, with resultant right-to-left shunting of blood through a patent ductus arteriosus and at times a patent foramen ovale.
(12 Dec 1998)
fetal Of or pertaining to a foetus, pertaining to in utero development after the embryonic period.
(18 Nov 1997)
persistent Continuing to exist in spite of interference or treatment, tending to recur.
(18 Nov 1997)
persistent anterior hyperplastic primary vitreous A unilateral congenital abnormality occurring in full-term infants; characterised by a retrolental fibrovascular membrane formed by persistent primary vitreous with remnants of the hyaloid artery and tunica vasculosa lentis; associated with leukokoria, microphthalmos, shallow anterior chamber, and elongated ciliary processes.
(05 Mar 2000)
persistent atrioventricular canal A condition that is caused when the atrial and ventricular septa fail to meet, as in normal development, resulting in a low atrial and high ventricular septal defect or a common atrioventricular canal.
Synonym: endocardial cushion defect.
(05 Mar 2000)
persistent chronic hepatitis A benign chronic hepatitis that may follow acute viral hepatitis A or B, or complicate bowel diseases; after six months, liver biopsy changes are mild, unlike active chronic hepatitis; rarely, if ever, progresses to cirrhosis, portal hypertension, or liver failure.
(05 Mar 2000)
persistent cloaca A condition in which the urorectal fold has failed to divide the cloaca of the embryo into rectal and urogenital portions.
Synonym: sinus urogenitalis, urogenital sinus.
(05 Mar 2000)
persistent ectopic pregnancy An ectopic pregnancy which has persistent viable tissue, secreting hCG after conservative surgery.
(05 Mar 2000)
persistent generalised lymphadenopathy A syndrome characterised by reactive hyperplasia of lymph nodes (of at least one month's duration and at two different body sites, not including the inguinal area) in patients infected with the human immunodeficiency virus. The lymph node lesions progress from benign reactive hyperplasia through a stage of mixed follicular hyperplasia, to follicular involution with lymphocyte depletion. Many go on to a malignant non-Hodgkin's lymphoma.
(05 Mar 2000)
persistent mullerian duct syndrome <syndrome> Familial disorder with presence of fallopian tube, uterus, and testis in a male. Deficient mullerian inhibitory substance secondary to Sertoli cell defect.
Synonym: hernia uteri inguinale.
(05 Mar 2000)
persistent posterior hyperplastic primary vitreous A unilateral congenital anomaly in full-term infants; associated with a congenital retinal fold and a vitreous membranous stalk containing remnants of the hyaloid artery.
(05 Mar 2000)
persistent tremor A tremor that is constant, whether the subject is at rest or moving.
Synonym: continuous tremor.
(05 Mar 2000)
persistent truncus arteriosus A congenital cardiovascular deformity resulting from failure of development of the spiral septum and consisting of a common arterial trunk opening out of both ventricles, the pulmonary arteries being given off from the ascending common trunk.
(05 Mar 2000)
persistent vegetative state A persistent loss of upper cortical function that may follow acute (e.g., infections, toxins, trauma or vascular) events or chronic (e.g., degenerative) events. The patient is bedridden and nutritional support is completely passive, either parenteral or via nasogastric tube. The patient does not require respiratory support or circulatory assistance for survival and is in a state of chronic wakefulness without awareness which may be accompanied by spontaneous eye opening, grunts or screams, brief smiles, sporadic movement of facial muscles and limbs. While the eyes blink upon stimulation, they do not do so in response to visual threats. Some patients chew or clamp their teeth. Urinary and faecal incontinence is universal.
(12 Dec 1998)
chronic persistent hepatitis <pathology> A form of hepatitis usually caused by hepatitis C or B, that consists of mild persistent liver inflammation.
Often a mild elevation of the liver enzymes will be seen on liver profile or SMAC 25 assay. Liver biopsy indicates persistent hepatitis.
Incidence: 1 in 1,000.
(02 Jan 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Persistent Fetal Circulation Syndrome - »õâ A syndrome of persistent PULMONARY HYPERTENSION in the newborn infant (INFANT, NEWBORN) without demonstrable HEART DISEASES. This neonatal condition can be caused by severe pulmonary vasoconstriction (reactive type), hypertrophy of pulmonary arterial muscle (hypertrophic type), or abnormally developed pulmonary arterioles (hypoplastic type). The newborn patient exhibits CYANOSIS and ACIDOSIS due to the persistence of fetal circulatory pattern of right-to-left shunting of blood through a patent ductus arteriosus (DUCTUS ARTERIOSUS, PATENT) and at times a patent foramen ovale (FORAMEN OVALE, PATENT).
    Synonyms : Circulation, Persistent Fetal, Persistent Fetal Circulation
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
persistent fetal circulation pulmonary hypertension in the postnatal period secondary to right-to-left shunting of the blood through the foramen ovale and ductus arteriosus.
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
persistent fetal circulation ABBR: PFC. A condition of newborns in which unoxygenated blood is shunted from the right to the left side of the heart through the ductus arteriosus and the foramen ovale, resulting in hypoxemia. It is caused by pul
Ãâó:
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • persistent
    °íÁýÇÏ´Â; Áý¿äÇÑ; ²÷ÀÓ¾ø´Â
  • persistent
    °íÁýÇÏ´Â;ºÒ±¼ÀÇ;Áö¼ÓÇÏ´Â;°íÁý;Áö¼Ó
  • fetal
    žÆÀÇ
  • fetal hemoglobin
    žƼº Ç÷»ö¼Ò;žƼº Çì¸ð±Û·Îºó
  • fetal position
    žÆÇü ÀÚ¼¼
  • circulation
    À¯Åë
  • circulation
    ¼øÈ¯;À¯Åë;À¯Æ÷;Àü´Þ;¹ßÇàºÎ¼ö;º¸±Þ(ÆÇ¸Å)ºÎ¼ö;(µµ¼­ÀÇ)´ëÃâºÎ¼ö;ÅëÈ­;À¯Åë¾îÀ½
  • circulation director
    (½Å¹®.ÀâÁöÀÇ)ºÎ¼öÈ®Àå´ã´çÀÌ»ç
  • circulation guarantee
    ºÎ¼ö º¸Áõ(±¤°íÁÖ¿¡ ´ëÇÑ)
  • controlled circulation
    (ÀâÁö.½Å¹®ÀÇ)¹«·á ¹èºÎ ºÎ¼ö(ÁõÁ¤,±¤°í ±ÇÀ¯¿ë)
  • currency circulation
    ÅëÈ­ À¯Åë
  • mass circulation
    (´ë·® ¹ßÇàÇÏ´Â) ÀÏ¹Ý ´ëÁß ÀâÁö
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á